E-LIB Suche - Ergebnisse für: Stetka, Jan

1

The glutaminase inhibitor CB-839 targets metabolic dependen..:

Usart, Marc ; Hansen, Nils ; Stetka, Jan...
Blood Advances. 8 (2024) 9 - p. 2312-2325 , 2024

Link: https://doi.org/10.1182/..

2

Loss of Dnmt3a increases self-renewal and resistance to peg..:

Usart, Marc ; Stetka, Jan ; Luque Paz, Damien...
Blood. 143 (2024) 24 - p. 2490-2503 , 2024

Link: https://doi.org/10.1182/..

3

Impact of Clonal Architecture on Clinical Course and Progno..:

Luque Paz, Damien ; Bader, Michael S. ; Nienhold, Ronny...
HemaSphere. 7 (2023) 5 - p. e885 , 2023

Link: https://doi.org/10.1097/..

4

Iron is a modifier of the phenotypes of JAK2-mutant myelopr..:

Stetka, Jan ; Usart, Marc ; Kubovcakova, Lucia...
Blood. , 2023

Link: https://doi.org/10.1182/..

5

Low Plasma Citrate Levels and Specific Transcriptional Sign..:

Koralkova, Pavla ; Belickova, Monika ; Kundrat, David...
Cancers. 13 (2021) 9 - p. 2161 , 2021

Link: https://doi.org/10.3390/..

6

Mouse models of myeloproliferative neoplasms for pre-clinic..:

Stetka, Jan ; Skoda, Radek C.
Biomedical Papers. 165 (2021) 1 - p. 26-33 , 2021

Link: https://doi.org/10.5507/..

7

Role of DNA Damage Response in Suppressing Malignant Progre..:

Stetka, Jan ; Gursky, Jan ; Liñan Velasquez, Julie...
Cancers. 12 (2020) 4 - p. 903 , 2020

Link: https://doi.org/10.3390/..

8

Impact of Clonal Architecture on Clinical Course and Progno..:

Luque Paz, Damien ; Bader, Michael S ; Nienhold, Ronny...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10158927/. , 2023

Link: http://www.ncbi.nlm.nih...

9

JAK2-V617F and interferon-α induce megakaryocyte-biased ste..:

Rao, Tata Nageswara ; Hansen, Nils ; Stetka, Jan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103999/. , 2021

Link: http://www.ncbi.nlm.nih...

10

Low Plasma Citrate Levels and Specific Transcriptional Sign..:

Koralkova, Pavla ; Belickova, Monika ; Kundrat, David...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125503/. , 2021

Link: http://www.ncbi.nlm.nih...

11

Role of DNA Damage Response in Suppressing Malignant Progre..:

Stetka, Jan ; Gursky, Jan ; Liñan Velasquez, Julie...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226398/. , 2020

Link: http://www.ncbi.nlm.nih...

12

Impact of Clonal Architecture on Clinical Course and Progno..:

Damien Luque Paz ; Michael S. Bader ; Ronny Nienhold...
http://journals.lww.com/10.1097/HS9.0000000000000885. , 2023

Link: https://doi.org/10.1097/..

13

Mouse models of myeloproliferative neoplasms for pre-clinic..:

Jan Stetka ; Radek C. Skoda
https://biomed.papers.upol.cz/artkey/bio-202101-0005_mouse-models-of-myeloproliferative-neoplasms-for-pre-clinical-testing-of-novel-therapeutic-agents.php. , 2021

Link: https://doi.org/10.5507/..

14

Low Plasma Citrate Levels and Specific Transcriptional Sign..:

Pavla Koralkova ; Monika Belickova ; David Kundrat...
Cancer Therapy. , 2021

Link: https://doi.org/10.3390/..

15

Low Plasma Citrate Levels and Specific Transcriptional Sign..:

Pavla Koralkova ; Monika Belickova ; David Kundrat...
https://www.mdpi.com/2072-6694/13/9/2161. , 2021

Link: https://doi.org/10.3390/..